In this respect, overexpression of BCL-XL has been already linked to survival advantage in circulating breast cancer cells [51] that is in line with anoikis-preventing up-regulation of BCL-XL by chemokine (C-C motif) ligand 19 (CCL19) demonstrated in this type of tumor cells [52]. This evidence concerns the gene BCL2L1 and breast cancer.